BioHarvest Sciences Inc.
BHSC
CNSX
Weiss Ratings | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Very Weak | |||
Risk Grade | E+ | |||
Reward Grade | E | |||
Rating Factors | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Good | |||
Efficiency Index | Very Weak | |||
Solvency Index | Very Weak | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.25 | |||
Price History | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 18.18% | |||
60-Day Total Return | 18.18% | |||
90-Day Total Return | 30.00% | |||
Year to Date Total Return | 23.81% | |||
1-Year Total Return | 15.56% | |||
2-Year Total Return | -25.71% | |||
3-Year Total Return | -35.80% | |||
5-Year Total Return | -- | |||
52-Week High % Change | -13.33% | |||
52-Week Low % Change | 85.71% | |||
Price | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.30 | |||
52-Week Low Price | $0.14 | |||
52-Week Low Price (Date) | May 25, 2023 | |||
52-Week High Price (Date) | Mar 19, 2024 | |||
Valuation | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 103.98M | |||
Enterprise Value | 113.65M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.02 | |||
Earnings Per Share Growth | -20.98% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 11.56 | |||
Price/Book (Q) | -16.05 | |||
Enterprise Value/Revenue (TTM) | 10.76 | |||
Price | $0.26 | |||
Enterprise Value/EBITDA (TTM) | -12.31 | |||
Enterprise Value/EBIT | -11.45 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 469.72M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 604 622 1186 | |||
Address | 1140-625 Howe Street Vancouver, BC V6C 2T6 | |||
Website | www.bioharvest.com | |||
Country | Canada | |||
Year Founded | -- | |||
Profitability | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -93.94% | |||
Profit Margin | -76.77% | |||
Management Effectiveness | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -61.64% | |||
Return on Equity | -- | |||
Income Statement | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 10.60M | |||
Total Revenue (TTM) | 10.60M | |||
Revenue Per Share | $0.02 | |||
Gross Profit (TTM) | 4.01M | |||
EBITDA (TTM) | -9.26M | |||
EBIT (TTM) | -9.95M | |||
Net Income (TTM) | -8.14M | |||
Net Income Avl. to Common (TTM) | -8.14M | |||
Total Revenue Growth (Q YOY) | 113.51% | |||
Earnings Growth (Q YOY) | 55.99% | |||
EPS Diluted (TTM) | -0.02 | |||
EPS Diluted Growth (Q YOY) | 56.98% | |||
Balance Sheet | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.56M | |||
Cash Per Share (Q) | $0.00 | |||
Total Current Assets (Q) | 4.72M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | -7.75M | |||
Current Ratio (Q) | 0.324 | |||
Book Value Per Share (Q) | -$0.02 | |||
Total Assets (Q) | 10.59M | |||
Total Current Liabilities (Q) | 14.60M | |||
Total Debt (Q) | 11.43M | |||
Total Liabilities (Q) | 18.34M | |||
Total Common Equity (Q) | -7.75M | |||
Cash Flow | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -1.45M | |||
Cash from Financing (TTM) | 8.78M | |||
Net Change in Cash (TTM) | -713.00K | |||
Levered Free Cash Flow (TTM) | -6.20M | |||
Cash from Operations (TTM) | -8.03M | |||